# Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser

> **NCT00491166** · PHASE1 · UNKNOWN · sponsor: **Ophthalmic Consultants of Boston** · enrollment: 10 (estimated)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Bromfenac ophthalmic solution

## Key facts

- **NCT ID:** NCT00491166
- **Lead sponsor:** Ophthalmic Consultants of Boston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2007-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00491166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00491166, "Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00491166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*